Corrigendum to "Different modulation of cellular transcription by adenovirus 5, ΔE1/E3 adenovirus and helper-dependent vectors" (DOI:10.1016/j.virusres.2007.05.019);Different modulation of cellular transcription by adenovirus 5, ΔE1/E3 adenovirus and helper-dependent vectors

Virus Research

Volumn 130, Issue 1-2, 2007, Pages 71-84

  Martina, Yuri ^a   Avitabile, Daniele ^a   Piersanti, Stefania ^a   Cherubini, Gioia ^a   Saggio, Isabella ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

Author keywords

Adenoviral vector; Chips; Gene therapy; Gutless vectors; Microarray

Indexed keywords

ADENOVIRUS VECTOR;

ADENOVIRUS 5; ARTICLE; CONTROLLED STUDY; GENE CASSETTE; HUMAN; HUMAN CELL; LIVER CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRAL GENE THERAPY; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 35748948671     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.12.012     Document Type: Erratum

References (56)

1. Alemany R., and Curiel D.T. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8 (2001) 1347-1353
2. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., and Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and Adenoviruses 2 and 5. Science 275 (1997) 1320-1323
3. Berk A.J. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24 (2005) 7673-7685
4. Bertos N.R., Wang A.H., and Yang X.J. Class II histone deacetylases: structure, function, and regulation. Biochem. Cell Biol. 79 (2001) 243-252
5. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
6. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., and Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22 (2003) 6610-6620
7. Chen L., Anton M., and Graham F.L. Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. Somat. Cell Mol. Genet. 22 (1996) 477-488
8. Chuah M.K., Collen D., and VandenDriessche T. Biosafety of adenoviral vectors. Curr. Gene Ther. 3 (2003) 527-543
9. Cordenonsi M., Dupont S., Maretto S., Insinga A., Imbriano C., and Piccolo S. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113 (2003) 301-314
10. Curiel D., and Douglas J. In: Press A. (Ed). Adenoviral Vectors for Gene Therapy (2002), Elsevier Science, San Diego, CA 677
11. Domchek S.M., and Weber B.L. Recent advances in breast cancer biology. Curr. Opin. Oncol. 14 (2002) 589-593
12. Gallimore P.H., and Turnell A.S. Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20 (2001) 7824-7835
13. Glotzer J.B., Saltik M., Chiocca S., Michou A.I., Moseley P., and Cotten M. Activation of heat-shock response by an adenovirus is essential for virus replication. Nature 407 (2000) 207-211
14. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1977) 59-74
15. Granberg F., Svensson C., Pettersson U., and Zhao H. Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture. Virology 343 (2005) 236-245
16. Granberg F., Svensson C., Pettersson U., and Zhao H. Adenovirus-induced alterations in host cell gene expression prior to the onset of viral gene expression. Virology 20 (2006) 20
17. Grompe M., and D'Andrea A. Fanconi anemia and DNA repair. Hum. Mol. Genet. 10 (2001) 2253-2259
18. Huang Y., Yan J., Lubet R., Kensler T.W., and Sutter T.R. Identification of novel transcriptional networks in response to treatment with the anticarcinogen 3H-1,2-dithiole-3-thione. Physiol. Genomics 24 (2006) 144-153 (Epub November 29, 2005)
19. Kinross K.M., Clark A.J., Iazzolino R.M., and Humbert P.O. E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 108 (2006) 886-895
20. Kochaneck S., Clemens P.R., Mitani K., Chen H.H., Chan S., and Caskey C.T. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full length dystrophoin and beta-galctosidase. Proc. Natl. Acad. Sci. 93 (1996) 5731-5736
21. Kremer E., and Perricaudet M. Adenovirus and adeno-associated virus mediated gene transfer. Br. Med. Bull. 51 (1995) 31-44
22. Liu Q., and Muruve D. Molecular basis of the inflammatory response to Adenovirus vectors. Gene Ther. 10 (2003) 935-940
23. Liu Q., and Muruve D.A. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10 (2003) 935-940
24. Liu W.M., Mei R., Di X., Ryder T.B., Hubbell E., Dee S., Webster T.A., Harrington C.A., Ho M.H., Baid J., and Smeekens S.P. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18 (2002) 1593-1599
25. Martin M.E., and Berk A.J. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 72 (1998) 3146-3154
26. Michou A.I., Santoro L., Christ M., Juillard V., Pavirani A., and Methali M. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4 (1997) 473-482
27. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41 (2005) 2449-2461
28. Morral N., O'Neal W., Rice K., Leland M., Kaplan J., Piedra P.A., Zhou H., Parks R.J., Velji R., Aguilar-Cordova E., Wadsworth S., Graham F.L., Kochanek S., Carey K.D., and Beaudet A.L. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12816-12821
29. Muruve D.A., Barnes M.J., Stillman I.E., and Libermann T.A. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10 (1999) 965-976
30. Nakabayashi H., Taketa K., Miyano K., Yamane T., and Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42 (1982) 3858-3863
31. Nevels M., Tauber B., Kremmer E., Spruss T., Wolf H., and Dobner T. Transforming potential of the adenovirus type 5 E4orf3 protein. J. Virol. 73 (1999) 1591-1600
32. Nevins J.R. Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199 (1995) 25-32
33. Parks R.J., Bramson J.L., Wan Y., Addison C.L., and Graham F.L. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J. Virol. 73 (1999) 8027-8034
34. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., and Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15 (2001) 3104-3117
35. Querido E., Marcellus R.C., Lai A., Charbonneau R., Teodoro J.G., Ketner G., and Branton P.E. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71 (1997) 3788-3798
36. Raper S.E., Haskal Z.J., Ye X., Pugh C., Furth E.E., Gao G.P., and Wilson J.M. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses. Hum. Gene Ther. 9 (1998) 671-679
37. Raper S.E., Yudkoff M., Chirmule N., Gao G.P., Nunes F., Haskal Z.J., Furth E.E., Propert K.J., Robinson M.B., Magosin S., Simoes H., Speicher L., Hughes J., Tazelaar J., Wivel N.A., Wilson J.M., and Batshaw M.L. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum. Gene Ther. 13 (2002) 163-175
38. Roth M.D., Cheng Q., Harui A., Basak S.K., Mitani K., Low T.A., and Kiertscher S.M. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. J. Immunol. 169 (2002) 4651-4656
39. Sandig V., Youil R., Bett A.J., Franlin L.L., Oshima M., Maione D., Wang F., Metzker M.L., Savino R., and Caskey C.T. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 1002-1007
40. Scibetta A.G., Copier J., Barrett A., Chaplin T., and Taylor-Papadimitriou J. Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells. Intervirology 48 (2005) 350-361
41. Shenk T. Adenoviridae: The Viruses and Their Replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology. 3rd ed. Vol. 2.2 (1996), Lippincott Williams & Wilkins, Philadelphia 2111-2148
42. Stilwell J.L., McCarty D.M., Negishi A., Superfine R., and Samulski R.J. Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression. J. Virol. 77 (2003) 12881-12885
43. Stilwell J.L., and Samulski R.J. Role of viral vectors and virion shells in cellular gene expression. Mol. Ther. 9 (2004) 337-346
44. Stratford-Perricaudet L.D., Makeh I., Perricaudet M., and Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90 (1992) 626-630
45. Tauber B., and Dobner T. Molecular regulation and biological function of adenovirus early genes: the E4 ORFs. Gene 278 (2001) 1-23
46. Tichopad A., Dilger M., Schwarz G., and Pfaffl M.W. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res. 31 (2003) e122
47. Trapnell B.C. Adenoviral vectors for gene transfer. Adv. Drug Deliv. Rev. 12 (1993) 185-199
48. Volk A.L., Rivera A.A., Page G.P., Salazar-Gonzalez J.F., Nettelbeck D.M., Matthews Q.L., and Curiel D.T. Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways. Cancer Gene Ther. (2004) 162-174
49. Weigel S., and Dobbelstein M. The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA. J. Virol. 74 (2000) 764-772
50. White E. Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 20 (2001) 7836-7846
51. Wickham T.J., Mathias P., Cheresh D.A., and Nemerow G.R. Integrins avb3 and avb5 promote adenovirus internalization but not virus attachment. Cell 73 (1993) 309-319
52. Wood M., Perrotte P., Onishi E., Harper M.E., Dinney C., Pagliaro L., and Wilson D.R. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther. 6 (1999) 367-372
53. Wu H., Goel V., and Haluska F.G. PTEN signaling pathways in melanoma. Oncogene 22 (2003) 3113-3122
54. Yamada K., Shimaoka M., Nagayama K., Hiroi T., Kiyono H., and Honda T. Bacterial invasion induces interleukin-7 receptor expression in colonic epithelial cell line, T84. Eur. J. Immunol. 27 (1997) 3456-3460
55. Yang Y., Nunes F.A., Berencsi K., Furth E.E., Gonczol E., and Wilson J.M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4407-4411
56. Zhao H., Granberg F., Elfineh L., Pettersson U., and Svensson C. Strategic attack on host cell gene expression during adenovirus infection. J. Virol. 77 (2003) 11006-11015